Amprius Technologies is executing a sharp revenue inflection, with 2026Q2 sales up 125.9% year-over-year to $34.0M and gross margin expanding to 27.3% from 8.9% a year earlier, driven by aerospace and defense orders.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 4, 2026 | -$0.03-25.0% vs -$0.02 | $34M+16.1% vs $29M |
Q2 2026 May 6, 2026 | -$0.04-100.0% vs -$0.02 | $29M+10.9% vs $26M |
Q2 2026 Mar 4, 2026 | -$0.01+73.7% vs -$0.04 | $25M+10.1% vs $23M |
Q4 2025 Nov 6, 2025 | -$0.03+50.0% vs -$0.06 | $21M-6.7% vs $23M |
Amprius Technologies NYSE: AMPX Q3 trend shift is shocking at face value, given the 68% correction in its share price over that period. During the quarter, shares were up as much as 3,877% from their 2024 lows, offering a compelling profit for early investors.
Agreement covers Amprius silicon-anode pouch cells from partial assembly through full cell production at CAMINUS's Indianapolis facility INDIANAPOLIS, Oct. 5, 2026 /PRNewswire/ -- CAMINUS (formerly EnPower), a U.S. manufacturer of lithium-ion battery cells and electrodes, today announced a contract manufacturing agreement with Amprius Technologies, Inc. (NYSE: AMPX), a developer and manufacturer of silicon-anode lithium-ion batteries. Under the agreement, CAMINUS will manufacture Amprius-designed pouch cells at its Indianapolis facility, adding domestic production capacity for Amprius customers in aviation, defense, and uncrewed systems.
Amprius Technologies NYSE: AMPX just received a new $75 million Department of War (DoW) grant that completely changes the narrative and strengthens the bull case. In short, the money shifts the company from a high-risk speculation with interesting technology to a primary, in-demand supplier for government needs, with an accelerated timeline to profitability.
[url="]Amprius Technologies[/url] (âAmpriusâ or the âCompanyâ) (NYSE: AMPX), a leader in high-performance batteries, has been awarded a grant of up to $
Benchmark AMPX against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Amprius Technologies, Inc. (AMPX)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $8.72 | $1.23B | -32.57 | 202.11% | -35.16% | -34.75% | — | |
| $1.05 | $93.08M | -5.49 | 10.52% | -7.43% | -15.32% | — | |
| $0.83 | $270.99M | -4.12 | 929.41% | -289.64% | -32.62% | — | |
| $4.28 | $2.63B | -6.92 | — | — | -35.5% | — | |
| $1.99 | $447.72M | -5.16 | 7.98% | -1273.87% | -18.32% | — | |
| $0.63 | $209.46M | 4.28 | 12.56% | 13.95% | 11.54% | — |
Amprius Technologies, Inc. (AMPX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Amprius Technologies, Inc. (AMPX) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 4, 2026·SEC
Jun 17, 2026·SEC
May 8, 2026·SEC
Get notified when AMPX posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Amprius Technologies, Inc. (AMPX) stock FAQ — growth, dividends, profitability & financials explained
Amprius Technologies, Inc. (AMPX) reported $109.2M in revenue over the trailing twelve months. Revenue was $73.0M in fiscal year 2025. That is 1460% more than the $4.7M of fiscal year 2020.
Amprius Technologies, Inc. (AMPX) grew revenue by 143.6% over the trailing twelve months, compared with the twelve months before.
No. Amprius Technologies, Inc. (AMPX) reported a net loss of $38.4M over the trailing twelve months.
Amprius Technologies, Inc. (AMPX) had a return on equity (ROE) of -34.8% over the trailing twelve months. A negative ROE means the company lost money over the period.
Amprius Technologies, Inc. (AMPX) had negative free cash flow of $58.4M over the trailing twelve months.
